NA
Nautilus Biotechnolgy, Inc.
NAUT · NASDAQ
$0.95 +2.88% (+$0.03)
1M +9.07%
Market Cap $121.5M
P/E Ratio -
Div. Yield -
ROE 37.58%
Bulios Fair Price
$0.79
17.3% downside
Trenutna cena
$0.95
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NAUT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
50 /100
Fair P/B 0.93x
P/S 639.42x
PEG N/A
Growth
0 /100
Declining Book val. growth 20.71%
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak FCF margin 27,295.30%
Op. margin 33,043.70%
Gross margin 919.47%
Quality
0 /100
Poor Asset turnover 0.00x
ROA 34.55%
ROIC 39.50%
Debt
100 /100
Low Current ratio 10.14x
Debt/Equity 0.21x
Net debt/EBITDA N/A
Stability
79 /100
Stable EPS volatility 15.26%
Profitable years 0
Beta 0.87x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NAUT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sujal Patel
Employees
127
Headquarters
Seattle
Prihajajoči dogodki
27 OKT.
Earnings
Upcoming earnings report